Indications for AFEDITAB CR:



Swallow whole. Initially 30mg once daily, titrate over 7–14 days; usual maintenance dose: 30–60mg once daily; max 90mg/day.


Not recommended.


Aortic stenosis. Angina. Severe obstructive coronary artery disease. Heart failure. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers: not recommended.

Pharmacologic Class:

Calcium channel blocker (CCB) (dihydropyridine).


Hypotension, angina and heart failure possible with β-blockers (esp. timolol). Potentiated by quinidine (monitor heart rate; adjust dose); diltiazem, verapamil, doxazosin, ketoconazole, itraconazole, fluconazole, cimetidine, quinupristin/dalfopristin, erythromycin, nefazodone, valproic acid, (reduce nifedipine dose); amprenavir, atazanavir, delavirine, fosamprenavir, indinavir, nelfinavir, ritonavir, grapefruit juice (avoid). Antagonized by rifampin, rifapentine, phenytoin, phenobarbitone, carbamazepine, St. John's Wort. Potentiates digoxin, tacrolimus (monitor). Antagonizes doxazosin. Hypotension possible with fentanyl. Monitor oral anticoagulants. Hyperglycemia with acarbose.

Adverse Reactions:

Headache, flushing/heat sensation, fatigue, dizziness, constipation, nausea, edema; rare: increased angina, acute MI.

How Supplied:

Tabs—100, 500

Pricing for AFEDITAB CR

30mg tablet (Qty: 60)
Appx. price $26